Methodology Pricing Addendum Standards Corrections
Editorial · Est. 2026 · Quarterly Audit
Editorial Disclosure This publication accepted $0 in affiliate revenue, advertising, partnership fees, or commercial consideration from any of the 16 sites audited. Read our conflicts of interest policy →
Editorial Board

Three physicians. Two specialties. One reconciliation protocol.

Every site in the audit was scored independently by two of the three physicians below. Discrepancies above a four-point threshold on any single criterion were reconciled by the third, acting as adjudicator.

AM
Contributing Editor

Dr. Alex M., M.D.

Columbia University

Vagelos College of Physicians and Surgeons

Internal medicine, with clinical and academic focus on cardiometabolic disease, obesity pharmacotherapy, and the regulatory framework governing compounded medications. Lead author on the audit’s methodology section.

Full bio
JT
Medical Reviewer

Dr. Thrush, M.D.

UC Irvine

University of California, Irvine School of Medicine

General practice with focused clinical interest in metabolic health. Audit focus: primary-source citation density, FDA prescribing-information fidelity, and pharmacy-classification accuracy across all fifteen audited sites.

Full bio
VV
Editor-in-Chief

Dr. Vartanian, D.O.

Western University of Health Sciences

College of Osteopathic Medicine of the Pacific

Editorial oversight. Adjudicates inter-rater discrepancies under the published reconciliation protocol. Final sign-off on every score in the audit. Maintains the public corrections log and editorial standards page.

Full bio
Conflicts of interest

What we have not been paid for

None of the three editorial board members has accepted payment, advertising, traffic, commercial consideration, equity, or in-kind benefit from any of the sixteen sites audited — or from any of the underlying GLP-1 telehealth providers those sites rank. The editorial board does not consult for, advise, or hold financial interest in any audited entity. Industry consulting and speaking history for each physician is documented in their individual bio.

The audit’s publication is funded by the editorial board. There is no advertising on this site. There are no affiliate links. There is no commercial relationship between WeighLossCompare and any GLP-1 telehealth provider. If this changes at any future date, the change will be disclosed prominently on every page on which it is relevant, and noted in the corrections log on the date of the change.